GAIN THERAPEUTICS, INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $590.5K | $34.8M | $36.9M |
| FY2022 | $495.3K | $18.9M | $7.3M |
| FY2023 | $449.1K | $12.6M | $11.8M |
| FY2024 | $328.3K | $7.3M | $10.4M |
| FY2025 | $300.1K | $18.6M | $20.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $590.5K | $34.8M | $36.9M |
| FY2022 | $495.3K | $18.9M | $7.3M |
| FY2023 | $449.1K | $12.6M | $11.8M |
| FY2024 | $328.3K | $7.3M | $10.4M |
| FY2025 | $300.1K | $18.6M | $20.8M |